Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masoud Mardani

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Annals of Thoracic Medicine|March 31, 2010
Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in IranMasoud Mardani, Payam Tabarsi, Zohre Mohammadtaheri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 5, 2020
Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: A retrospective single center studyShohra Qaderi, Masoud Mardani, Asghar Shah, et al.
Journal of Medical Virology|February 5, 2015
Molecular and serological findings in suspected patients with Crimean-Congo hemorrhagic fever virus in IranHelen Karlberg, Batool Sharifi-Mood, Mehrdad Mousavi-Jazi, et al.
Case Reports in Neurology|February 28, 2014
Trigeminal neuralgia as the first clinical manifestation of anti-hu paraneoplastic syndrome induced by a borderline ovarian mucinous tumorHossein Kalanie, Ali Amini Harandi, Masoud Mardani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Management of central venous catheters in patients with cancer and candidemiaIssam Raad, Hend Hanna, Maha Boktour, et al.
The American Journal of Medicine|March 21, 2002
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancerGerald P Bodey, Masoud Mardani, Hend A Hanna, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2022
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populationsPayam Tabarsi, Nassim Anjidani, Ramin Shahpari, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 8, 2014
Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidatesMasoud Mardani, Maham Farshidpour, Mohsen Nekoonam, et al.
Infection Control and Hospital Epidemiology|September 25, 2002
Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancerIssam Raad, Jeffrey Tarrand, Hend Hanna, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2022
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trialPayam Tabarsi, Nassim Anjidani, Ramin Shahpari, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Annals of Thoracic Medicine|March 31, 2010
Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in IranMasoud Mardani, Payam Tabarsi, Zohre Mohammadtaheri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 5, 2020
Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: A retrospective single center studyShohra Qaderi, Masoud Mardani, Asghar Shah, et al.
Journal of Medical Virology|February 5, 2015
Molecular and serological findings in suspected patients with Crimean-Congo hemorrhagic fever virus in IranHelen Karlberg, Batool Sharifi-Mood, Mehrdad Mousavi-Jazi, et al.
Case Reports in Neurology|February 28, 2014
Trigeminal neuralgia as the first clinical manifestation of anti-hu paraneoplastic syndrome induced by a borderline ovarian mucinous tumorHossein Kalanie, Ali Amini Harandi, Masoud Mardani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Management of central venous catheters in patients with cancer and candidemiaIssam Raad, Hend Hanna, Maha Boktour, et al.
The American Journal of Medicine|March 21, 2002
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancerGerald P Bodey, Masoud Mardani, Hend A Hanna, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2022
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populationsPayam Tabarsi, Nassim Anjidani, Ramin Shahpari, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 8, 2014
Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidatesMasoud Mardani, Maham Farshidpour, Mohsen Nekoonam, et al.
Infection Control and Hospital Epidemiology|September 25, 2002
Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancerIssam Raad, Jeffrey Tarrand, Hend Hanna, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2022
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trialPayam Tabarsi, Nassim Anjidani, Ramin Shahpari, et al.
Pageof 8